98%
921
2 minutes
20
Purpose: To present the visual and anatomical outcomes for patients with intraocular gas placed during vitreoretinal surgery who subsequently underwent surgery wherein general anesthesia with nitrous oxide was used.
Methods: The authors reviewed the charts of patients who had undergone vitreoretinal surgery where a long-acting gas tamponade had been used. These patients underwent additional surgery for a variety of reasons at five different institutions and had nitrous oxide used during general anesthesia. The authors reviewed the preoperative and postoperative findings for patients receiving nitrous oxide following vitreoretinal surgery with gas tamponade.
Results: The authors reviewed findings for five eyes of five patients. All eyes that underwent general anesthesia using nitrous oxide had significant preexisting intraocular gas bubbles ranging from 40% to 90%, and the surgical procedures lasted from 1 to 4 hours. These eyes were followed from 2 months to 9 years (median follow-up, 4 years). Four of five eyes had a final vision of 20/200 or worse and significant optic atrophy at the time of the last follow-up examination. Three eyes had no light perception.
Conclusion: The use of nitrous oxide during general anesthesia in gas-filled eyes may have disastrous visual results caused by gas expansion and elevated intraocular pressure. Patients must be advised of the potentially catastrophic results of undergoing general anesthesia before their intraocular gas bubble has resorbed. The use of nitrous oxide for patients with intraocular gas should be avoided. It may be prudent for patients with intraocular gas to wear notification bracelets warning anesthesiologists about the presence of intraocular gas lest emergency surgery be needed by a patient unable to advise anesthesia personnel about the potential danger.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1097/00006982-200210000-00006 | DOI Listing |
J Am Chem Soc
September 2025
Institute of Integrated Research, Institute of Science Tokyo, 4259 Nagatsuta, Midori-ku, Yokohama 226-8501, Japan.
Upgrading methane to value-added chemicals is significant but still challenging. Well-designed catalysts are required to activate methane. Extensive efforts have been dedicated to the catalytic conversion of methane over transition-metal-containing catalysts.
View Article and Find Full Text PDFNat Commun
September 2025
Institute of Agrobiological Sciences, National Agriculture and Food Research Organization (NARO), Tsukuba, Ibaraki, Japan.
Soybeans fix atmospheric N through symbiosis with rhizobia. The relationship between rhizobia and soybeans, particularly those with high nitrous oxide (NO)-reducing (NOR) activities, can be leveraged to reduce NO emissions from agricultural soils. However, inoculating soybeans with these rhizobia under field conditions often fails because of the competition from indigenous rhizobia that possess low or no NOR activity.
View Article and Find Full Text PDFClin Toxicol (Phila)
September 2025
School of Clinical Medicine, UNSW Sydney, Sydney, Australia.
Introduction: Nitrous oxide is an inhaled anaesthetic used recreationally that is neurotoxic. Corneal nerve parameters were assessed in patients with nitrous oxide toxicity.
Methods: Four individuals underwent clinical, electrophysiological and corneal confocal microscopy assessment.
Drug Alcohol Rev
September 2025
National Drug and Alcohol Research Centre, UNSW Sydney, Sydney, Australia.
Introduction: Increasing harms associated with nitrous oxide use have raised concerns, but limited evidence exists to inform harm reduction. This study aimed to identify how nitrous oxide is sourced, the products/forms used, awareness of health risks, engagement in harm reduction and experience of neurological symptoms.
Methods: Data were collected via annual interviews (2021-2023) with cross-sectional convenience samples of Australians who regularly used ecstasy/MDMA and/or other illicit stimulants and reported past 6-month use of nitrous oxide (2021 n = 379; 2022 n = 315; 2023 n = 284).
Int J Obstet Anesth
August 2025
Department of Anesthesiology, Perioperative and Pain Medicine, Stanford University School of Medicine, Stanford, CA, USA.
Background: Virtual reality (VR) platforms have emerged as a non-pharmacologic labor analgesic. We hypothesized that VR would be non-inferior to nitrous oxide (NO) for satisfaction with labor pain relief. The primary aim compared efficacy of VR to NO for satisfaction with pain relief during labor.
View Article and Find Full Text PDF